RankingsPricing
  1. JP-listed companies
  2. TAKARA BIO INC.
  3. Financials
  4. Depreciation & amortization

TAKARA BIO INC.JP:4974

Market cap
¥93.2B
P/E ratio
-10.4x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Mar 31, 20253,611-15.61%
Mar 31, 20244,279+5.65%
Mar 31, 20234,050+13.96%
Mar 31, 20223,554+10.37%
Mar 31, 20213,220+10.24%
Mar 31, 20202,921+8.55%
Mar 31, 20192,691+4.79%
Mar 31, 20182,568+49.13%
Mar 31, 20171,722+2.07%
Mar 31, 20161,687+25.24%
Mar 31, 20151,347

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)